Thomas Shrader
Stock Analyst at BTIG
(4.34)
# 1,203
Out of 4,501 analysts
737
Total ratings
42%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPS COMPASS Pathways | Maintained: Buy | $14 → $25 | $13.64 | +83.28% | 15 | Jul 7, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $12 | $3.92 | +206.12% | 7 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Buy | $23 | $6.97 | +229.99% | 11 | Jul 6, 2026 | |
| SER Serina Therapeutics | Initiated Coverage: Buy | $8 | $2.14 | +273.83% | 1 | Jul 1, 2026 | |
| IVVD Invivyd | Maintained: Buy | $10 | $0.7834 | +1,176.49% | 8 | Jun 30, 2026 | |
| NRXP NRx Pharmaceuticals | Maintained: Buy | $25 | $4.19 | +496.66% | 13 | Jun 22, 2026 | |
| NVAX Novavax | Maintained: Buy | $19 | $9.33 | +103.64% | 8 | Jun 11, 2026 | |
| GANX Gain Therapeutics | Maintained: Buy | $5 | $1.80 | +177.78% | 29 | May 26, 2026 | |
| NTHI NeOnc Technologies Holdings | Rated: Buy | $15 | $4.49 | +234.08% | 2 | May 26, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $28 | $26.48 | +5.74% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $24.34 | +64.34% | 1 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $42.48 | +48.31% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $25.68 | +51.87% | 37 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $31.38 | +24.28% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $199.15 | - | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.61 | +272.67% | 25 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.63 | +204.18% | 29 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $147 | $77.84 | +88.85% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.52 | +58.73% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $2.07 | +334.78% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.39 | +234.73% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $5.26 | +204.18% | 24 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 | $58.21 | +52.89% | 26 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $15.55 | +2.89% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.94 | - | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $200 | $14.25 | +1,303.51% | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.08 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.18 | n/a | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.60 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $0.0001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.12 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7404 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $85.89 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $9.09 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.80 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.72 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 | $11.21 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $13 | $3.82 | n/a | 5 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $4.33 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.81 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $18.13 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $15.85 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $28.92 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.711 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.78 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $8.76 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $10.99 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.0001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $1.01 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.50 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.44 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.17 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $29.73 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $5.32 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $26 | $9.46 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $33.49 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $11.07 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $66.39 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.18 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $8.00 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $43.92 | n/a | 2 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.01605 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $38 | $7.61 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $3.85 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $129.83 | n/a | 1 | Mar 23, 2015 |
COMPASS Pathways
Jul 7, 2026
Maintained: Buy
Price Target: $14 → $25
Current: $13.64
Upside: +83.28%
Opus Genetics
Jul 6, 2026
Maintained: Buy
Price Target: $12
Current: $3.92
Upside: +206.12%
Arcturus Therapeutics Holdings
Jul 6, 2026
Maintained: Buy
Price Target: $23
Current: $6.97
Upside: +229.99%
Serina Therapeutics
Jul 1, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.14
Upside: +273.83%
Invivyd
Jun 30, 2026
Maintained: Buy
Price Target: $10
Current: $0.7834
Upside: +1,176.49%
NRx Pharmaceuticals
Jun 22, 2026
Maintained: Buy
Price Target: $25
Current: $4.19
Upside: +496.66%
Novavax
Jun 11, 2026
Maintained: Buy
Price Target: $19
Current: $9.33
Upside: +103.64%
Gain Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $5
Current: $1.80
Upside: +177.78%
NeOnc Technologies Holdings
May 26, 2026
Rated: Buy
Price Target: $15
Current: $4.49
Upside: +234.08%
Alto Neuroscience
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $26.48
Upside: +5.74%
May 13, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $24.34
Upside: +64.34%
May 12, 2026
Maintained: Buy
Price Target: $63
Current: $42.48
Upside: +48.31%
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $25.68
Upside: +51.87%
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $31.38
Upside: +24.28%
Apr 20, 2026
Maintained: Hold
Price Target: n/a
Current: $199.15
Upside: -
Apr 2, 2026
Maintained: Buy
Price Target: $6
Current: $1.61
Upside: +272.67%
Apr 2, 2026
Maintained: Buy
Price Target: $8
Current: $2.63
Upside: +204.18%
Mar 30, 2026
Maintained: Buy
Price Target: $147
Current: $77.84
Upside: +88.85%
Mar 26, 2026
Maintained: Buy
Price Target: $4
Current: $2.52
Upside: +58.73%
Mar 17, 2026
Maintained: Buy
Price Target: $9
Current: $2.07
Upside: +334.78%
Mar 16, 2026
Maintained: Buy
Price Target: $8
Current: $2.39
Upside: +234.73%
Mar 16, 2026
Maintained: Buy
Price Target: $16
Current: $5.26
Upside: +204.18%
Mar 2, 2026
Maintained: Buy
Price Target: $89
Current: $58.21
Upside: +52.89%
Nov 17, 2025
Maintained: Buy
Price Target: $16
Current: $15.55
Upside: +2.89%
Nov 3, 2025
Maintained: Hold
Price Target: n/a
Current: $1.94
Upside: -
Jul 21, 2025
Maintained: Buy
Price Target: $8 → $200
Current: $14.25
Upside: +1,303.51%
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $5.08
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $9
Current: $3.18
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Mar 19, 2024
Maintained: Buy
Price Target: $32
Current: $0.0001
Upside: n/a
Feb 28, 2024
Maintained: Buy
Price Target: $33
Current: $1.12
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $0.7404
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $85.89
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $9.09
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $5.80
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $4.72
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $216
Current: $11.21
Upside: n/a
Mar 27, 2023
Maintained: Buy
Price Target: $87 → $13
Current: $3.82
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $4.33
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.81
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $18.13
Upside: n/a
Mar 5, 2023
Maintained: Buy
Price Target: $56
Current: $15.85
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $28.92
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.711
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $36.78
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $8.76
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $60
Current: $10.99
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Jun 10, 2021
Maintained: Buy
Price Target: $5.5
Current: $1.01
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $1.50
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: n/a
Current: $3.44
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.17
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $29.73
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $5.32
Upside: n/a
Nov 7, 2017
Maintained: Buy
Price Target: $32 → $26
Current: $9.46
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $33.49
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $11.07
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $66.39
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $1.18
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $8.00
Upside: n/a
Jul 24, 2017
Reiterated: Buy
Price Target: $24
Current: $43.92
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.01605
Upside: n/a
Jun 21, 2017
Maintained: Buy
Price Target: $32 → $38
Current: $7.61
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $3.85
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $129.83
Upside: n/a